| Ident. | Authors (with country if any) | Title |
|---|
| 000183 (2011) |
Masayuki Watanabe [Japon, Canada] ; Douglas P. Munoz [Canada] | Probing basal ganglia functions by saccade eye movements |
| 000229 (2011) |
Yuen-Sum Lau [États-Unis] ; Gaurav Patki [États-Unis] ; Kaberi Das-Panja [États-Unis] ; Wei-Dong Le [États-Unis] ; S. Omar Ahmad [États-Unis] | Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration |
| 000231 (2011) |
Beate Winner [États-Unis, Allemagne] ; Zacharias Kohl [Allemagne] ; Fred H. Gage [États-Unis] | Neurodegenerative disease and adult neurogenesis |
| 000284 (2011) |
Maria Papathanou [Suède] ; Sarah Rose [Royaume-Uni] ; Andrew Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6‐OHDA‐lesioned rats |
| 000289 (2011) |
Guadalupe Soria [Espagne] ; Esther Aguilar [Espagne] ; Raúl Tudela [Espagne] ; Joaquim Mullol [Espagne] ; Anna M. Planas [Espagne] ; Concepci Marin [Espagne] | In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese‐enhanced magnetic resonance imaging in the 6‐hydroxydopamine rat model |
| 000353 (2011) |
Carmen Agustín-Pav N [Royaume-Uni] ; John Parkinson [Royaume-Uni] ; Mei-See Man [Royaume-Uni] ; Angela C. Roberts [Royaume-Uni] | Contribution of the amygdala, but not orbitofrontal or medial prefrontal cortices, to the expression of flavour preferences in marmoset monkeys |
| 000412 (2011) |
Saskia Van Stockum [Nouvelle-Zélande] ; Michael R. Macaskill [Nouvelle-Zélande] ; Daniel Myall [Nouvelle-Zélande] ; Tim J. Anderson [Nouvelle-Zélande] | A perceptual discrimination task abnormally facilitates reflexive saccades in Parkinson’s disease |
| 000488 (2010) |
Li Rebekah Feng [États-Unis] ; Howard J. Federoff [États-Unis] ; Stefano Vicini [États-Unis] ; Kathleen A. Maguire-Zeiss [États-Unis] | α‐Synuclein mediates alterations in membrane conductance: a potential role for α‐synuclein oligomers in cell vulnerability |
| 000518 (2010) |
Federica Agosta [Italie] ; Vladimir S. Kosti [Serbie] ; Sebastiano Galantucci [Italie] ; Šarlota Mesaroš [Italie, Serbie] ; Marina Svetel [Serbie] ; Elisabetta Pagani [Italie] ; Elka Stefanova [Serbie] ; Massimo Filippi [Italie] | The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study |
| 000556 (2010) |
Romulo Fuentes [États-Unis] ; Per Petersson [Suède] ; Miguel A. L. Nicolelis [États-Unis, Brésil] | Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach |
| 000727 (2010) |
Jens Clausen [Allemagne] | Ethical brain stimulation – neuroethics of deep brain stimulation in research and clinical practice |
| 000766 (2010) |
Ayse Ulusoy [Suède] ; Fabia Febbraro [Danemark] ; Poul H. Jensen [Danemark] ; Deniz Kirik [Suède] ; Marina Romero-Ramos [Suède, Danemark] | Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology |
| 000785 (2010) |
Esther Florin [Allemagne] ; Joachim Gross [Royaume-Uni] ; Christiane Reck [Allemagne] ; Mohammad Maarouf [Allemagne] ; Alfons Schnitzler [Allemagne] ; Volker Sturm [Allemagne] ; Gereon R. Fink [Allemagne] ; Lars Timmermann [Allemagne] | Causality between local field potentials of the subthalamic nucleus and electromyograms of forearm muscles in Parkinson’s disease |
| 000912 (2009) |
David A. Price [États-Unis] ; Alex A. Martinez [États-Unis] ; Alexandre Seillier [États-Unis] ; Wouter Koek [États-Unis] ; Yolanda Acosta [États-Unis] ; Elizabeth Fernandez [États-Unis] ; Randy Strong [États-Unis] ; Beat Lutz [Allemagne] ; Giovanni Marsicano [France] ; James L. Roberts [États-Unis] ; Andrea Giuffrida [États-Unis] | WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease |
| 000918 (2009) |
Alice Nieuwboer [Belgique] ; Sarah Vercruysse [Belgique] ; Peter Feys [Belgique] ; Oron Levin [Belgique] ; Joke Spildooren [Belgique] ; Stephan Swinnen [Belgique] | Upper limb movement interruptions are correlated to freezing of gait in Parkinson’s disease |
| 000931 (2009) |
Thibaud Lebouvier [France] ; Tanguy Chaumette [France] ; Sébastien Paillusson [France] ; Charles Duyckaerts [France] ; Stanislas Bruley Des Varannes [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France] | The second brain and Parkinson’s disease |
| 000A15 (2009) |
J. Coste [France] ; L. Ouchchane [France] ; L. Sarry [France] ; P. Derost [France] ; F. Durif [France] ; J. Gabrillargues [France] ; S. Hemm [France] ; J. J. Lemaire [France] | New electrophysiological mapping combined with MRI in parkinsonian’s subthalamic region |
| 000A21 (2009) |
Naroa Ibarretxe-Bilbao [Espagne] ; Carme Junque [Espagne] ; Eduardo Tolosa [Espagne] ; Maria-Jose Marti [Espagne] ; Francesc Valldeoriola [Espagne] ; Nuria Bargallo [Espagne] ; Mojtaba Zarei [Royaume-Uni] | Neuroanatomical correlates of impaired decision‐making and facial emotion recognition in early Parkinson’s disease |
| 000A73 (2009) |
Na K. Kim [Corée du Sud] ; Byung H. Choi [Corée du Sud] ; Xian Huang [Corée du Sud] ; Brian J. Snyder [Canada] ; Shefqat Bukhari [Canada] ; Tae-Ho Kong [Corée du Sud] ; Hyeonseon Park [Corée du Sud] ; Hyung C. Park [Corée du Sud] ; So R. Park [Corée du Sud] ; Yoon Ha [Corée du Sud] | Granulocyte–macrophage colony‐stimulating factor promotes survival of dopaminergic neurons in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced murine Parkinson’s disease model |
| 000B00 (2009) |
Christian Beste [Allemagne] ; Isabel Dziobek [Allemagne] ; Horst Hielscher [Allemagne] ; Rita Willemssen [Allemagne] ; Michael Falkenstein [Allemagne] | Effects of stimulus–response compatibility on inhibitory processes in Parkinson’s disease |
| 000B01 (2009) |
C. Marin [Espagne] ; E. Aguilar [Espagne] ; G. Mengod [Espagne] ; R. Cortés [Espagne] ; J. A. Obeso [Espagne] | Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats |
